SMTL ID : 6mxt.1

Crystal structure of human beta2 adrenergic receptor bound to salmeterol and Nb71

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.96 Å

Oligo State

hetero-1-1-mer

Ligands

1 x K5Y: salmeterol(Non-covalent)

K5Y.1: 20 residues within 4Å: Chain A: W.244, D.248, V.249, V.252, C.326, D.327, F.328, F.329, Y.334, S.338, S.342, F.396, N.400, H.403, I.410, R.411, Y.415, I.416, N.419, Y.423 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:W.244, A:V.249, A:V.252, A:F.328, A:F.328, A:F.329, A:F.396, A:F.396, A:Y.415, A:Y.415 Hydrogen bonds: A:D.248, A:F.328, A:S.338, A:S.342, A:S.342, A:N.419, A:N.419, A:Y.423 pi-Stacking: A:F.397

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 5 residues within 4Å: Chain A: N.238, C.319, Y.320, E.322, C.325 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:C.319, A:E.322, A:C.325, H2O.1

3 x NI: NICKEL (II) ION(Non-covalent)

NI.3: 2 residues within 4Å: Chain A: E.242, H.307 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:E.242, A:H.307, H2O.1 NI.8: 2 residues within 4Å: Chain B: H.119, H.121 2 PLIP interactions: 2 interactions with chain B Metal complexes: B:H.119, B:H.121 NI.9: 3 residues within 4Å: Chain B: H.117, H.120, H.122 2 PLIP interactions: 2 interactions with chain B Metal complexes: B:H.117, B:H.122

1 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.4: 4 residues within 4Å: Chain A: S.355, H.376, L.379, L.382 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.382

1 x HTO: HEPTANE-1,2,3-TRIOL(Non-covalent)

HTO.5: 8 residues within 4Å: Chain A: E.11, D.20, E.22, T.26, G.30, L.32, Q.105, R.145 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:E.22, A:Q.105 Hydrogen bonds: A:L.32, A:R.145

1 x OLA: OLEIC ACID(Non-covalent)

OLA.6: 5 residues within 4Å: Chain A: L.298, T.299, W.308, A.333, Y.334 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.298, A:Y.334, A:Y.334

1 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)

P33.7: 6 residues within 4Å: Chain A: L.32, L.33, K.35, E.45, Q.105, M.106 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.35, A:E.45 Water bridges: A:E.45

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Masureel, M. et al., Structural insights into binding specificity, efficacy and bias of a beta2AR partial agonist. Nat. Chem. Biol. (2018)

Release Date

2018-11-14

Peptides

Endolysin, Beta-2 adrenergic receptor chimera: A
nanobody Nb71: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
N

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Endolysin, Beta-2 adrenergic receptor chimera

nanobody Nb71